Related Experiment Videos
Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients
Noritaka Onoda1, Tetsuya Kashiwagi, Tadashi Nakamura
1Division of Endocrinology and Metabolism, Sekishinkai Sayama Hospital, and Nippon Medical University 2nd Department of Internal Medicine, Japan. noritaka-onoda@sayamahp.org
Abstract:
Although parathyroidectomy (PTX) is the ultimate treatment for secondary hyperparathyroidism (SHPT) that is resistant to medical treatment, recent advances in ultrasonographic techniques have increased the treatment options in Japan. Percutaneous ethanol injection therapy (PEIT) of the parathyroid was approved under the national health insurance system in 2004, and there have been trials of direct injection of vitamin D (VD) preparations. We followed 30 patients for at least 1 year who had undergone PEIT at the same institution. The overall mean concentration of intact parathyroid hormone (PTH) fell from 865.3+/-388.4 pg/mL to 291.9+/-277.8 pg/mL, or 34% of the pretreatment value. The effect was even more pronounced for one or two glands, with 68.4% reaching the target of intact PTH
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis I: Introduction